Jamie W. Rhoads
( out of 178 reviews )

Jamie W. Rhoads, MD

Languages spoken: English

Clinical Locations

Midvalley Health Center

Murray
801-581-2955

Veterans Administration Medical Center

Dermatology Clinic
Salt Lake City

  • Dr. Jamie Rhoads has specialized interest in medical dermatology and infectious disease dermatology. She has completed a two-year fellowship in psoriasis and published research in this area. She enjoys caring for patients with any general dermatologic concerns.

    Specialties

    Board Certification

    National Board of Medical Examiners

    Patient Rating

    4.9 /5
    ( out of 178 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    October 29, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Jamie Woodcock Rhoads has been my dermatologist for years and she is wonderful. Always thorough, friendly, knowledgeable and approachable with an excellent team.

    September 28, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Good doctor and office staff was great. Good care

    July 19, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Very nice and easy to talk to

    July 19, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    There's not a finer doctor than Dr. Rhoads she takes the absolute best care of me in all aspects. Extremely knowledgeable and cares about her patients

    July 12, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I feel she is very professional and takes an interest In my health. She is also friendle

    July 04, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Wonderful Doctor who really cares! She has taken care if me for years!

    June 21, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Love Dr. Rhodes - excellent care

    June 20, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    Dr Rhoads is very kind and helpful. I highly recommend her.

    June 18, 2024
    UNIVERSITY OF UTAH MIDVALLEY HEALTH CENTER

    I recommend Dr. Jamie Rhoads to all who are frustrated with their current medical treatment. She cares.

    See More Patient Comments

  • Dr. Jamie Rhoads has specialized interest in medical dermatology and infectious disease dermatology. She has completed a two-year fellowship in psoriasis and published research in this area. She enjoys caring for patients with any general dermatologic concerns.

    Board Certification and Academic Information

    Academic Departments Dermatology -Primary
    Board Certification
    National Board of Medical Examiners

    Education history

    Residency Dermatology - University of Utah Resident
    Clinical Investigation - University of Utah M.S.C.I
    Research Fellow Dermatology - University of Utah Research Fellow
    Internal Medicine - University of Florida College of Medicine-Jacksonville Intern
    Professional Medical Medicine - University of Florida College of Medicine M.D.
    Majors: Chemistry, Biochemistry; Minors: Biology, Math - Florida State University B.S.

    Selected Publications

    Journal Article

    1. Rhoads JLW, Christensen L, Westerdahl S, Stevens V, Chapman WW, Conway M (2024). Automatic Extraction of Skin and Soft Tissue Infection Status from Clinical Notes. Stud Health Technol Inform, 310, 579-583. (Read full article)
    2. Rhoads JLW, Malatestinic WN, Burge R, Ganz ML, Duffin KC (2023). Factors Associated with Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data. J Psoriasis Psoriatic Arthritis, (0).
    3. Snyder AM, Taliercio VL, Rich BE, Brandenberger AU, Webber LB, Biber JE, Hess R, Rhoads JL, Secrest AM (2023). Quality of Life and Avoiding Triggers of Atopic Dermatitis Flares: A Qualitative Study. Skinmed, 21(4), 233-235. (Read full article)
    4. Hopkins ZH, Jimenez A, Taliercio VL, Clarke JT, Hansen CB, Hull CM, Rhoads JLW, Zone JJ, Sahni VN, Kean J, Secrest AM (2023). Skin-Related Quality of Life During Autoimmune Bullous Disease Course. JAMA Dermatol, 159(11), 1185-1194. (Read full article)
    5. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2023). Atopic Dermatitis: A Qualitative Study on the Burdens of Living with Itchiness. J Clin Aesthet Dermatol, 16(7), 22-25. (Read full article)
    6. Bolender CM, Jimenez A, Clarke JT, Willson TM, Stevens VW, Rhoads JLW (2022). Incidence of Dermatomyositis in a Nationwide Cohort Study of US Veterans. JAMA Dermatol, 158(11), 1321-1323. (Read full article)
    7. Snyder AM, Brandenberger AU, Taliercio VL, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2022). Quality of Life Among Family of Patients with Atopic Dermatitis and Psoriasis. Int J Behav Med. (Read full article)
    8. Skemp-Dymond G, Lebiedz-Odrobina D, Zuromski LM, Rhoads JLW, Tebo AE (2021). Assessment of a line immunoassay for the detection of mi-2 antibodies. Am J Clin Pathol, 157, 506-509. (Read full article)
    9. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of Pain From Atopic Dermatitis: Interview and Focus Group Study With Patients and Their Families. JMIR Dermatol, 4(2), e29826. (Read full article)
    10. Flint ND, Rhoads JLW, Carlisle R, Ferrel M, Hopkins ZH, Secrest AM (2021). The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone. Dermatol Online J, 27(8). (Read full article)
    11. Beshay A, Petersen M, Rhoads JLW (2021). Severe EGFR inhibitor-induced acneiform eruption responding to dapsone. Dermatol Online J, 27(7). (Read full article)
    12. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42–48.
    13. Taliercio VL, Snyder AM, Webber LB, Langner AU, Rich BE, Beshay AP, Ose D, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). The disruptiveness of itchiness from psoriasis: A qualitative study of the impact of a single symptom on quality of life. J Clin Aesthet Dermatol, 14(6), 42-48. (Read full article)
    14. Snyder AM, Taliercio VL, Brandenberger AU, Rich BE, Webber LB, Beshay AP, Biber JE, Hess R, Rhoads JLW, Secrest AM (2021). Effects of pain from atopic dermatitis: Interview and focus group study with patients and their families. JMIR Dermatol, 4(2).
    15. Rhoads JLW, Willson TM, Sutton JD, Spivak ES, Samore MH, Stevens VW (2019). Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections. Clin Infect Dis, 72(4), 675-681. (Read full article)
    16. Walsh JA, McFadden M, Woodcock J, Clegg DO, Helliwell P, Dommasch E, Gelfand JM, Krueger GG, Duffin KC (2013). Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort. J Am Acad Dermatol, 69(6), 931-7. (Read full article)
    17. Duffin KC, Woodcock J, Krueger GG (2010). Genetic variations associated with psoriasis and psoriatic arthritis found by genome-wide association. Dermatol Ther, 23(2), 101-13. (Read full article)

    Case Report

    1. Dao DP, Sahni VN, Sahni DR, Abbott J, Rhoads JLW (2021). Vasculitis with granulomatosis: An atypical presentation of giant cell arteritis. JAAD Case Rep, 16, 124-126. (Read full article)
    2. Lo MC, Woodcock JL (2011). Case of EBV-induced adrenal insufficiency, cardiac tamponade, and pleural effusions. Fed Pract, 28(7), 23-27.

    Letter

    1. Westerdahl S, Hull CM, Clarke JT, Hansen CB, Rhoads JLW (2020). A single-center, retrospective record review of malignancy prevalence in patients with dermatomyositis with anti-transcription intermediary factor 1γ antibodies via line immunoassay versus immunoprecipitation. [Letter to the editor]. J Am Acad Dermatol, 84(2), 559-561. (Read full article)

  • Clinical Trials